Risk factors for death by COVID-19, public hospital in Ciudad Juárez, México
Background: On March 11, 2020, a COVID-19 pandemic was declared for a novel coronavirus named SARS-CoV-2 virus. This virus induces a severe inflammatory response, producing death in patients with COVID-19 disease, in México, in 2021, COVID-19 mortality becomes the second cause of death, with higher mortality in persons with previous conditions like chronic non-communicable diseases. Objective: To identify the risk factors associated with deaths in patients diagnosed with COVID-19 from January 1 to December 31, 2021, hospitalized in a clinic of IMSS in Ciudad Juárez, Chihuahua, México. Material and methods: An observational, cross-sectional, analytical study was used. Information from patients with confirmed diagnostic of COVID-19 was collected from the SINOLAVE platform and medical records. To identify risk factors, univariate and multivariate logistic regression was used. Results: A total of 277 patients were included, 51.62% were male, the rest were female. Death from COVID-19 were associated with age (OR: 1.03; 95%CI: 1.01 - 1.06, p ≤ 0.001), chronic kidney disease (OR: 3.20; 95%CI: 1.58 - 6.48, p ≤ 0.001) chronic neurological diseases (OR: 5.27; 95%CI: 1.30 - 20.03, p ≤ 0.05), and chronic obstructive pulmonary diseases (OR: 12.24; 95%CI: 1.44 - 103.82, p ≤ 0.05); the proportion of death by sex were similar in the study Conclusion: Age, chronic kidney disease, chronic neurological disease, and chronic obstructive pulmonary diseases were associated with death in patients with COVID-19. It’s important to prevent and control chronic non-communicable diseases; the distribution was similar in both sexes.
Authors
- Magdalena Medrano-Ramos (ORCID: https://orcid.org/0000-0002-1806-258X)
- et al
- Beatriz Araceli Díaz-Apodaca
- Miriam Angélica Luján-Montes
Institutions
- Universidad Autónoma de Ciudad Juárez (MX)
- Mexican Social Security Institute (MX)
- Hospital General De Zona (MX)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-11-05
- DOI
- https://doi.org/10.5281/zenodo.17537546
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00